How patients use medical cannabis alongside seizure medicines
Utilization, tolerability, and perception of medical cannabis use in patients with seizures.
AI Summary
This retrospective study examined how 1,940 people with seizures used medical cannabis products from 2015 to 2023. Among seizure-only patients, most used one product and one administration route at their last visit. Although products varied by year, 86.8% of patients received formulations containing both CBD and THC. Dosing varied widely, and most patients received products with a high CBD-to-THC ratio. Pediatric patients were dispensed higher CBD doses than other age groups, while the median daily CBD dose was about 75% below the maintenance dose recommended for an FDA-approved purified CBD product.
Patients generally viewed medical cannabis as beneficial, but affordability was a concern. Seizure frequency improved in 67.6% of patients over the study period, although the study design cannot establish that cannabis caused the improvement. Most patients who reported taking other medicines—76.2%—were also using at least one antiseizure medication, showing that medical cannabis was commonly used alongside conventional treatment. Older adults reported adverse events more often than younger age groups, highlighting the importance of individualized dosing, monitoring, and discussion of possible interactions with healthcare professionals.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More CBD research papers you might find interesting.
A lab method measures 17 cannabinoids across five hemp product types
CBD showed limited adaptive-functioning differences versus placebo in boys…
NMR profiling finds THC predominates in Moroccan beldia extracts
Explore More Research
Stay informed about the latest cannabis science.